Who owns DRUGS MADE IN AMER ACQ II CO?
- Ticker: DMII
- CUSIP Number: g2851k104
Tip: Access positions for across all investors
Analyze quarterly positions in Drugs Made In Amer Acq Ii with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Drugs Made In Amer Acq Ii stock
Who bought or sold DRUGS MADE IN AMER ACQ II CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Karpus Investment Management | 2.8M | $28M | 7% | Jun 2026 |
|
| Magnetar Financial | 2.7M | $27M | 0% | Jun 2026 |
|
| MMCAP International Inc. SPC | 2.7M | $27M | 0% | Jun 2026 |
|
| Glazer Capital | 2.3M | $24M | 0% | Jun 2026 |
|
| Millennium Management | 2.0M | $20M | 1% | Jun 2026 |
|
| Hudson Bay Capital Management | 2.0M | $20M | 0% | Jun 2026 |
|
| Wolverine Asset Management | 1.9M | $19M | 3% | Jun 2026 |
|
| Tenor Capital Management | 1.5M | $15M | 0% | Jun 2026 |
|
| Polar Securities | 1.5M | $15M | 0% | Jun 2026 |
|
| D. E. Shaw & Co | 1.5M | $15M | 6% | Jun 2026 |
|
| CNH Partners | 1.1M | $11M | 2% | Jun 2026 |
|
| Aristeia Capital | 1.1M | $11M | 0% | Jun 2026 |
|
| Crossingbridge Advisors | 1.1M | $11M | 214% | Jun 2026 |
|
| Vivaldi Asset Management | 1.1M | $11M | 0% | Jun 2026 |
|
| OMERS Administration Corporation | 1.0M | $10M | 0% | Jun 2026 |
|
| Davidson Kempner Capital Management | 1.0M | $10M | 0% | Jun 2026 |
|
| Picton Mahoney Asset Management | 888k | $8.9M | 1% | Jun 2026 |
|
| Two Sigma Investments | 887k | $8.9M | 0% | Jun 2026 |
|
| Moore Capital Management | 750k | $7.5M | 0% | Jun 2026 |
|
| Context Capital Management | 750k | $7.5M | 0% | Jun 2026 |
|
| Ghisallo Capital Management | 750k | $7.5M | 0% | Jun 2026 |
|
| Mercuria Capital Strategies | 750k | $7.5M | 0% | Jun 2026 |
|
| Westchester Capital Management | 622k | $6.3M | 24% | Jun 2026 |
|
| Radcliffe Capital Management | 576k | $5.8M | 0% | Jun 2026 |
|
| HighTower Advisors | 567k | $5.7M | -21% | Jun 2026 |
|
| Jpmorgan Chase & Co | 556k | $5.6M | 147% | Jun 2026 |
|
| Heights Capital Management | 519k | $5.2M | 0% | Jun 2026 |
|
| TIG Advisors | 500k | $5.0M | 100% | Jun 2026 |
|
| HBK Investments | 500k | $5.0M | 0% | Jun 2026 |
|
| BlueCrest Capital Management | 500k | $5.0M | 0% | Jun 2026 |
|
| Sona Asset Management | 500k | $5.0M | 0% | Jun 2026 |
|
| Whitebox Advisors | 450k | $4.5M | 0% | Jun 2026 |
|
| Wealthspring Capital | 400k | $4.0M | -1% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 395k | $4.0M | 0% | Jun 2026 |
|
| Logan Stone Capital | 382k | $3.8M | 3274% | Jun 2026 |
|
| Cantor Fitzgerald, L. P. | 363k | $3.7M | 100% | Jun 2026 |
|
| Commonwealth of Pennsylvania | 350k | $3.5M | 0% | Jun 2026 |
|
| Lineage Point Capital | 336k | $3.4M | 0% | Jun 2026 |
|
| Rivernorth Capital Management | 300k | $3.0M | 0% | Jun 2026 |
|
| Mint Tower Capital Management B.V. | 250k | $2.5M | 0% | Jun 2026 |
|
| Highbridge Capital Management | 225k | $2.2M | 100% | Mar 2026 |
|
| Periscope Capital | 225k | $2.3M | 0% | Jun 2026 |
|
| Clear Street Group | 225k | $2.3M | 1365% | Jun 2026 |
|
| Kepos Capital | 210k | $2.1M | 100% | Jun 2026 |
|
| Verition Fund Management | 203k | $2.0M | 0% | Jun 2026 |
|
| Shaolin Capital Management | 181k | $1.8M | -58% | Jun 2026 |
|
| Gabelli Securities | 180k | $1.8M | 0% | Jun 2026 |
|
| Limestone Investment Advisors | 151k | $1.5M | 1169% | Jun 2026 |
|
| HGC Investment Management | 150k | $1.5M | -88% | Jun 2026 |
|
| Gabelli Funds | 133k | $1.3M | -18% | Jun 2026 |
|
| Schonfeld Strategic Advisors | 112k | $1.1M | 0% | Jun 2026 |
|
| Toronto-Dominion Bank | 104k | $1.0M | 0% | Jun 2026 |
|
| DLD Asset Management | 100k | $1.0M | -10% | Jun 2026 |
|
| Centiva Capital | 100k | $1.0M | 0% | Jun 2026 |
|
| Peak6 | 100k | $1.0M | 0% | Jun 2026 |
|
| PenderFund Capital Management | 80k | $800k | 60% | Jun 2026 |
|
| SRS Capital Advisors | 66k | $664k | 100% | Jun 2026 |
|
| Deltec Asset Management | 50k | $503k | 0% | Jun 2026 |
|
| UBS Group | 44k | $439k | -2% | Jun 2026 |
|
| Geode Capital Management | 40k | $399k | 0% | Jun 2026 |
|
| Abc Arbitrage Sa | 35k | $352k | -12% | Jun 2026 |
|
| Oakmont Partners | 31k | $308k | 0% | Jun 2026 |
|
| Virtu Financial | 30k | $299k | -26% | Jun 2026 |
|
| Robinson Capital Management | 25k | $252k | 150% | Jun 2026 |
|
| Royal Bank of Canada | 19k | $192k | -53% | Jun 2026 |
|
| Mizuho Securities Usa | 19k | $184k | 0% | Jun 2026 |
|
| Tuttle Tactical Management | 11k | $108k | 100% | Jun 2026 |
|
| Morgan Stanley | 119.00 | $1.2k | -30% | Mar 2026 |
|
Who sold out of Drugs Made In Amer Acq Ii?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Healthcare Of Ontario Pension Plan Trust Fund | Mar 2026 | 2.0M | $20M |
| OZ Management | Mar 2026 | 500k | $5.0M |
| Parallax Volatility Advisers | Mar 2026 | 134k | $1.3M |
| CSS | Mar 2026 | 110k | $1.1M |